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ENDOVASCULAR coil embolization has become a wide-ly performed procedure for the treatment of cere-bral aneurysms. The purpose of this treatment is to 
prevent the cerebral aneurysm from rupturing. Although 
this procedure has both low morbidity and mortality rates, 
late recanalization and rupturing of coiled aneurysms are 
both major concerns with their inherent risks and costs.
Histological analysis has previously revealed that the 
mechanism of acute aneurysm occlusion by endovascular 
coil embolization is the disruption of the flow and clot for-
mation in the aneurysm, which in turn induce clot matura-
tion and aneurysm fibrosis.5,17 At the level of the aneurysm 
neck, a fibrous connective tissue was shown covering the 
lesion’s neck. In an animal study, a radiolucent gap at the 
aneurysm neck between the coil mass in the aneurysm and 
the lumen of the parent artery was observed on angiogra-
phy studies when this fibrous tissue was thick.9 This sign 
was also observed in humans and named the white-collar 
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FPD = flat-panel detector; ICA = internal carotid artery; MCA = middle cerebral artery; MRA = MR angiography; ROC = receiver operating characteristic; VA = vertebral 
artery; WCS = white-collar sign. 
sUbMitteD December 21, 2015. aCCePteD February 10, 2016.
inClUDe when Citing Published online May 13, 2016; DOI: 10.3171/2016.2.JNS152976.
White-collar sign as a predictor of outcome after 
endovascular treatment for cerebral aneurysms
Kenji Fukuda, MD, toshio higashi, MD, PhD, Masakazu okawa, MD, PhD,  
Mitsutoshi iwaasa, MD, PhD, tsutomu Yoshioka, MD, PhD, and tooru inoue, MD, PhD
Department of Neurosurgery, Fukuoka University Hospital, and School of Medicine, Fukuoka University, Fukuoka, Japan
objeCtive The white-collar sign (WCS) is known as a thick neointimal tissue formation at the aneurysm neck after 
endovascular coil embolization of cerebral aneurysms, which may prevent aneurysm recanalization. The purpose of this 
study was to evaluate factors involved in the appearance of WCS and to identify radiological and clinical outcomes of 
treated aneurysms with WCS.
MethoDs The study included 140 patients with 149 aneurysms in which it was possible to confirm the aneurysm neck 
between the aneurysm sac and parent artery by using conventional angiography. The WCS was defined as a radiolucent 
band at the aneurysm neck on the angiogram at 6 months after initial embolization. The radiological outcome was evalu-
ated using MR angiography.
resUlts In 23 of 149 aneurysms (15.4%), a WCS appeared. The WCS-positive group had a significantly smaller neck 
size (3.3 ± 0.8 mm vs 4.2 ± 1.1 mm, p < 0.001) and smaller aneurysm size (4.3 ± 0.9 mm vs 6.0 ± 2.1 mm, p < 0.001) 
than the WCS-negative group. Multivariate analysis revealed that WCS appearance was associated with small neck size 
(OR 0.376, 95% CI 0.179–0.787; p = 0.009). In 106 of 149 aneurysms, the rate of complete occlusion was significantly 
higher in the WCS-positive group (18/18, 100%) than in the WCS-negative group (n = 54/88, 61.4%; p = 0.001) in the 
mean follow-up period of 31.0 ± 9.7 months (range 5–52 months). Neither major recanalization nor rupture of the aneu-
rysm occurred in the WCS-positive group.
ConClUsions Appearance of the WCS was associated with complete occlusion and good clinical outcome after en-
dovascular coil embolization. The WCS would help to determine the prognosis of cerebral aneurysms after endovascular 
treatment.
http://thejns.org/doi/abs/10.3171/2016.2.JNS152976
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sign (WCS).3 This sign means the complete separation be-
tween aneurysm sac and parent artery, which may indicate 
the healing of the aneurysm. However, the nature of the 
WCS is not well known in humans. Moreover, the long-
term result in patients with WCS has never been reported. 
The purpose of this study was to evaluate factors in the ap-
pearance of WCS and to identify radiological and clinical 
outcomes of treated aneurysms with WCS.
Methods
study Population
We conducted a retrospective study of patients with 
saccular intracranial aneurysms treated by endovascu-
lar coil embolization between April 2011 and December 
2013. A total of 201 consecutive patients with 211 saccu-
lar intracranial aneurysms were treated by endovascular 
coil embolization (Fig. 1). From this group 51 aneurysms 
were excluded because it was impossible to detect the an-
eurysm neck between the lesion’s sac and the parent artery 
clearly by using conventional digital subtraction angiog-
raphy (DSA) as aneurysms involving the parent artery. In 
addition, 11 aneurysms were lost to follow-up. Therefore, 
140 patients (29 men, 20.7%; mean age 58.6 ± 12.9 years) 
with 149 intracranial aneurysms were included in this 
study. A total of 119 aneurysms were unruptured and 30 
aneurysms were ruptured. The aneurysm characteristics 
were retrospectively examined by reviewing the medical 
records. This study was approved by the hospital ethics 
committee.
endovascular Procedures
In cases of unruptured aneurysm, coil embolization 
was performed under local or general anesthesia accord-
ing to the location and size of the aneurysm. Patients with 
a ruptured aneurysm underwent treatment using general 
anesthesia. The coils used in the treatment were bare plati-
num coils, bioactive coils (Cerecyte [Micrus Endovascu-
lar] or Matrix2 [Stryker]), or hydrogel coils (Hydrocoil 
[MicroVention, Inc.]). These coils were selected by the 
surgeon on a patient-by-patient basis. Balloon remodeling 
or stent-assisted technique was performed according to 
the aneurysm size, neck size, location, and clinical pre-
sentation (ruptured or unruptured). The Enterprise VRD 
(Codman) or the Neuroform (Stryker) stent was used for 
the stent-assisted coil embolization. The percentage of 
packing density was calculated as the ratio of coil volume 
to aneurysm volume × 100. Patients with unruptured an-
eurysms received a dose of dual antiplatelet medication 
(100 mg aspirin and 75 mg clopidogrel) 1 week before the 
procedure. Patients with ruptured aneurysms received a 
dose of single antiplatelet medication (100 mg aspirin) on 
the day of the procedure. The dual antiplatelet medica-
tion was maintained for 1–3 months and then changed to 
aspirin monotherapy for 3–6 months in patients with un-
ruptured lesions without a stent, and aspirin monotherapy 
was continued indefinitely in patients with unruptured 
aneurysms who had a stent. Aspirin monotherapy was 
maintained for 3–6 months in patients with ruptured an-
eurysms. All endovascular treatments were performed by 
5 interventionalists (T.H., K.F., M.O., M.I., and T.Y.). The 
Fig. 1. Flowchart demonstrating the selection process used for the present study. 
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status of postembolization lesions was evaluated based on 
the Raymond grading scale.13
evaluation of wCs
Follow-up angiography was conducted mainly at 6 
months (range 5–12 months). A WCS was defined as 
the appearance of a radiolucent separation at the aneu-
rysm neck between the coil mass and the parent artery 
on DSA and on nonsubtracted images at follow-up an-
giography (Fig. 2). So, the embolization status of an an-
eurysm with WCS corresponded to complete occlusion. 
All angiographic imaging studies were acquired using 
a biplane flat-panel detector (FPD) angiographic system 
(Artis zee BA Twin, Siemens AG). The C-arm angle was 
set to clearly observe the neck of the aneurysm between 
the aneurysm sac and the lumen of the parent artery. The 
images were acquired in a 1024 × 1024 matrix by using 
a 22-cm field of view (FOV) FPD or a 720 × 720 matrix 
by using a 16-cm FOV FPD and were then evaluated on 
a workstation (syngo X-Workplace, Siemens AG). Image 
edge enhancement was adjusted to correct for the coil 
artifact influence. Nonionic iodinated contrast material 
(Iopamiron 300, Bayer Healthcare Japan) was injected 
manually at a flow rate of 2.5–3.5 ml/second (5–7 ml of 
total volume). These angiographic conditions were the 
same at the time of treatment and at the 6-month follow-
up period.
outcome assessment
Clinical and radiological follow-up investigations were 
performed every 6–12 months in each patient. Radiologi-
cal examination was performed using MR angiography 
(MRA). The MRI studies were acquired using a 1.5-T unit 
(Achieva or Ingenia, Philips Medical Systems). Imaging 
parameters of MRA using a 3D time of flight technique 
were TR 25.0, TE 6.9, 15° flip angle, 150 × 150–mm FOV, 
512 × 512 matrix, and 0.6-mm effective thickness. Cases 
with stent-assisted coil embolization were excluded from 
this analysis because stent artifacts prevent accurate as-
sessment of embolization status using MRA. Clinical 
outcome was evaluated whether the rupture occurred in 
an unruptured aneurysm or was the rerupture of a rup-
tured aneurysm. The status of a coiled aneurysm on initial 
postembolization angiography, at the follow-up angiogra-
phy including WCS determination, and at the follow-up 
MRA was analyzed by 2 neurointerventionalists (T.H. and 
K.F.). When there was any discrepancy, a decision was 
made by another neurointerventionalist (M.I.).
statistical analyses
Statistical analyses were performed using SPSS soft-
ware (IBM). Categorical variables are presented as num-
ber and percentage, and continuous variables are present-
ed as the mean ± SD. The chi-square test or Fisher exact 
test was performed to analyze categorical variables as ap-
propriate. Where necessary, an independent t-test or the 
Mann-Whitney U-test was used for unpaired continuous 
variables, and a paired t-test or Wilcoxon signed-rank sum 
test was used for paired continuous variables. Multivari-
ate logistic regression analysis was performed to identify 
factors associated with the appearance of a WCS. These 
Fig. 2. a: Angiogram showing a left VA–posterior inferior cerebellar artery aneurysm at the time of endovascular treatment. b: Im-
mediately after coil embolization, complete occlusion was achieved. C and D: Follow-up imaging performed 6 months after 
treatment showing the appearance of a radiolucent band (WCS) (arrowheads) between the coil mass and the parent artery on a 
DSA image (C) and on a nonsubtracted image (D). e: MRA imaging showing the maintenance of the complete occlusion of a coiled 
aneurysm at 36 months after treatment.
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factors were selected according to the reported factors of 
aneurysm recurrence: the neck size, the aneurysm size, 
hemorrhagic presentation, packing density, and the in-
complete initial occlusion status.10,12,14,15 To ascertain the 
continuous value from multivariate analysis as the cutoff 
point for the prediction of the appearance of a WCS, re-
ceiver operating characteristic (ROC) curve analyses were 
also performed. Differences were defined as significant at 
a probability level of p < 0.05.
results
Patient and aneurysm Characteristics
The characteristics of the study population are listed 
in Table 1: 140 patients (29 men [20.7%], mean age 58.6 
± 12.9 years) with 149 intracranial aneurysms were ana-
lyzed. A total of 119 aneurysms (79.9%) were unruptured, 
and 30 aneurysms (20.1%) were ruptured. There were no 
significant differences in the frequency of conventional 
risk factors between the unruptured and ruptured groups. 
The average aneurysm size was 5.7 ± 2.2 mm (range 2.4–
16.0 mm), the average aneurysm neck size was 4.1 ± 1.1 
mm (range 1.8–8.2 mm), and the average dome-to-neck 
ratio was 1.3 ± 0.3 (range 0.8–2.0). The neck size was sig-
nificantly larger in the unruptured group than in the rup-
tured group (4.2 ± 1.1 mm vs 3.6 ± 1.1 mm, p = 0.02). 
The aneurysm size and dome-to-neck ratio were similar in 
both groups. Aneurysms on the anterior communicating 
artery (ACoA) and anterior cerebral artery (ACA) were 
more frequent in the ruptured group (66.7% vs 16.0%), 
whereas aneurysms on the internal carotid artery (ICA), 
middle cerebral artery (MCA), and vertebral artery/basi-
lar artery (VA/BA) were more frequent in the unruptured 
group (p < 0.001).
Factors of wCs appearance
A WCS was confirmed in 23 of 149 cases (15.4%) 
mainly at 6-month follow-up angiography (range 5–6 
months) (Table 2). In univariate logistic regression analy-
sis, no significant difference was observed between the 
WCS-positive and WCS-negative groups in any of the fol-
lowing characteristics: age; sex; aneurysm location; type 
of aneurysm (sidewall type or bifurcation type); rupture 
status (unruptured or ruptured); initial embolization sta-
tus (complete occlusion, residual neck, or residual aneu-
rysm); packing density; coil variety (use of bioactive coil 
or hydrogel coil); or stent use. However, the WCS-positive 
group had significantly smaller neck size (3.3 ± 0.8 mm 
vs 4.2 ± 1.1 mm, p < 0.001) and smaller aneurysm size 
(4.3 ± 0.9 mm vs 6.0 ± 2.1 mm, p < 0.001) compared with 
the WCS-negative group. In multivariate logistic regres-








Patients n = 140 n = 110 n = 30
 Age in yrs, ± SD† 58.6 ± 12.9 58.7 ± 12.4 58.2 ± 15.1 0.86
 Male sex 29 (20.7) 22 (20.0) 7 (23.3) 0.69
 Risk factors
  Hypertension 70 (50.0) 54 (49.1) 16 (53.3) 0.68
  Diabetes  
   mellitus
13 (9.3) 11 (10.0) 2 (6.7) 0.57
  Dyslipidemia 28 (20.0) 21 (19.1) 7 (23.3) 0.61
  Smokers 40 (28.6) 32 (29.1) 8 (26.7) 0.79
Aneurysms n = 149 n = 119 n = 30
 Location
  ICA 89 (59.7) 81 (68.1) 8 (26.7)
  ACA/ACoA 39 (26.2) 19 (16.0) 20 (66.7)
  MCA 3 (2.0) 3 (2.5) 0
  VA/BA 18 (12.1) 16 (13.5) 2 (6.7) <0.001
 Size†
  Overall size, mm 5.7 ± 2.2 5.8 ± 2.1 5.4 ± 2.1 0.33
  Neck size, mm 4.1 ± 1.1 4.2 ± 1.1 3.6 ± 1.1 0.02
  Dome-to-neck  
   ratio
1.3 ± 0.3 1.3 ± 0.3 1.3 ± 0.3 0.73
* Values are presented as number (%), unless otherwise indicated.
† Mean values are presented ± SD. 






n = 126 p Value
Age in yrs, ± SD† 58.3 ± 13.0 58.6 ± 13.0 0.9
Male sex 5 (21.7) 24 (19.1) 0.78
Aneurysm location
 ICA 15 (65.2) 74 (58.7)
 ACA/ACoA 3 (13.0) 36 (28.6)
 MCA 0 3 (2.4)
 VA/BA 5 (21.7) 13 (10.3) 0.23
Aneurysm size†
 Overall size 4.3 ± 0.9 6.0 ± 2.1 <0.001
 Neck size 3.3 ± 0.8 4.2 ± 1.1 <0.001
 Dome-to-neck ratio 1.3 ± 0.3 1.3 ± 0.3 0.81
Aneurysm type
 Sidewall 17 (73.9) 84 (66.7)
 Bifurcation 6 (26.1) 42 (33.3) 0.49
Rupture status
 Unruptured 20 (87.0) 99 (78.6)
 Ruptured 3 (13.0) 27 (21.4) 0.57
Initial treatment result
 Embolization status
  Complete occlusion 5 (21.7) 32 (25.4)
  Residual neck 12 (52.2) 73 (57.9)
  Residual aneurysm 6 (26.1) 21 (16.7) 0.56
 Packing density, %† 20.7 ± 5.5 22.6 ± 6.3 0.18
 Use of bioactive coil 5 (21.7) 19 (15.1) 0.54
 Use of hydrogel coil 0 (0) 8 (6.3) 0.61
 Use of stent 5 (21.7) 38 (30.2) 0.41
* Values are presented as number (%), unless otherwise indicated.
† Mean values are presented ± SD.
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sion analysis, the independent predictor of a WCS was a 
small neck (OR 0.376, 95% CI 0.179–0.787; p = 0.009) 
(Table 3). In the ROC curve analysis, a neck size of 4.1 
was determined as the most reliable cutoff value for pre-
dicting the appearance of a WCS (95% CI 0.662–0.846) 
(Fig. 3). Based on this cutoff value, the sensitivity and 
specificity were 87.0% and 51.6%, respectively. The posi-
tive and negative predictive values were 24.7% and 95.6%, 
respectively.
Of 126 aneurysms without WCS, the angiography 
showed complete occlusion in 56 aneurysms (44.4%), the 
residual neck in 62 (49.2%), and residual aneurysm in 8 
(6.3%), mainly at 6-month follow-up (range 5–12 months). 
Compared with the complete occlusion aneurysms with-
out WCS, the WCS-positive aneurysms had significantly 
smaller neck size (3.3 ± 0.8 mm vs 4.2 ± 0.9 mm, p < 
0.001) and smaller aneurysm size (4.3 ± 0.9 mm vs 5.7 ± 
1.8 mm, p < 0.001).
radiological and Clinical outcomes
The radiological and clinical results of coiled aneu-
rysms were analyzed after the evaluation of WCS. Forty-
three aneurysms were excluded because they were treated 
with stents. Therefore, 106 of 149 aneurysms were ana-
lyzed at a mean follow-up of 31.0 ± 9.7 months (range 5–52 
months). The rate of complete occlusion was significantly 
higher in the WCS-positive group (18/18, 100%) than in 
the WCS-negative group (54/88, 61.4%; p = 0.001) (Table 
4). The overall major recanalization rates are low for both 
the WCS-positive and -negative groups (0/18, 0% vs 6/88, 
6.8%; p = 0.254). Retreatment was performed in those 6 
patients at 5–26 months. No rupture occurred in any pa-
tient in this period.
Patients with complete occlusion without the WCS at 
6-month follow-up also had good radiological and clini-
cal outcomes. Complete occlusion was maintained and no 
rupture occurred in any patient.
Discussion
A WCS is a radiolucent gap between the coil mass in 
the aneurysm and the lumen of the parent artery observed 
on angiography between 14 days and 6 months after endo-
vascular coil embolization, which indicates a formation of 
thick neointimal tissue at the neck of the aneurysm.9 Gon-
zalez et al. first reported the appearance of WCS in human 
beings for 2 cases of cerebral aneurysms.3 However, the 
prognosis of a coiled aneurysm with WCS is unknown. 
This is the first study to evaluate the role of WCS in the 
radiological and clinical outcome.
In our study, the presence of a WCS was confirmed in 
15.4% of cerebral aneurysms at 5–6 months after endovas-
cular coil embolization. The most important factor in the 
appearance of WCS was small neck size. The appearance 
of a WCS was not correlated with either the location of 
the aneurysm or the initial angiographic status. A previous 
study has demonstrated that the rate of a WCS appearance 
was 6.9%, and that a small neck correlated with the appear-
ance of WCS only in cases of unruptured aneurysm.4 Our 
study revealed that WCS tended to appear in the small-
necked aneurysms after treatment in both unruptured and 
ruptured aneurysms. Furthermore, the WCS-positive aneu-
rysms had significantly smaller neck size and smaller an-
eurysm size compared with the aneurysms with complete 
occlusion without WCS. The neointimal thickening would 
be promoted at the neck of these coiled aneurysms, which 
table 3. independent predictive value for the appearance of  
the wCs
Variable Adjusted OR 95% CI p Value
Neck size 0.376 0.179–0.787 0.009
Aneurysm size 0.669 0.437–1.024 0.06
Sidewall type aneurysm 0.882 0.268–2.906 0.84
Ruptured aneurysm 4.887 0.835–28.598 0.08
Packing density, % 1.016 0.924–1.117 0.74
Complete occlusion at 
initial treatment
0.528 0.153–1.824 0.31
Fig. 3. The ROC curve analysis indicates that a neck size of 4.1 mm 
(arrow) is the most reliable cutoff value for predicting the appearance of 
WCS. AUC = area under the curve.










 Complete occlusion 18 (100) 54 (61.4)
 Residual neck 0 (0) 28 (31.8)
 Residual aneurysm 0 (0) 6 (6.8) 0.001
Retreatment 0 (0) 6 (6.8) 0.254
Subarachnoid hemorrhage 0 (0) 0 (0) 1
* Values are presented as number (%), unless otherwise indicated.
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prevents any further aneurysmal filling. Although bioactive 
coils were developed to prevent the recurrence of aneurysm 
by promoting organized thrombus formation and growth 
of connective tissue into the aneurysm,1,9 they were not as-
sociated with the appearance of WCS in our study. Recent 
randomized trials revealed that bioactive or hydrogel coils 
were not associated with prevention of major recurrence of 
aneurysm when compared with bare platinum coils.6,8,18
Our study also demonstrated that the outcome of treated 
aneurysms with WCS was excellent in the follow-up pe-
riod. Complete occlusion was maintained at an average of 
31 months in all cases with a WCS. Neither major recana-
lization nor aneurysm rupture occurred. Factors of aneu-
rysm recurrence were reported to be a neck size > 4 mm, 
an aneurysm size > 10 mm, initial angiographic status, and 
a hemorrhagic presentation.10,12,14,15 The rate of retreatment 
for previously coiled aneurysms was reported as 6%–33%, 
whereas that of aneurysm rupture was very low.7,13,14,18 Con-
sistent with a previous histological study,9 our study sup-
posed that WCS would indicate a healing of the aneurysm. 
The prognosis of coiled aneurysms will be confirmed by 
evaluating WCS.
A limitation of this study is that the average aneurysm 
size of 5.7 mm in our sample was relatively small. This is 
because larger aneurysms tend to involve the parent artery, 
and the precise confirmation of the neck between aneu-
rysm and parent artery is difficult achieve by conventional 
angiography, which is unable to evaluate WCS. Indeed, 51 
of 211 saccular aneurysms were excluded for that reason in 
this study. Also, cases with stent treatment were excluded 
in the radiological outcome of WCS because the emboliza-
tion status could not be evaluated due to the stent artifact 
on MRA. Stent-assisted coil embolization tends to be per-
formed for wide-necked aneurysms (neck size is one of 
the risk factors for recanalization).11 So, the rate of major 
recanalization was low and the clinical result was excel-
lent in both WCS-positive and WCS-negative cases in this 
study. 
A previous study has reported that the stability of em-
bolization status was decided mainly at 6 months.16 The 
prognosis of coiled aneurysms with adequate occlusion 
(complete occlusion or small neck remnant) at 6 months 
was expected to be excellent. After 6 months, the factors 
of late recanalization were the presence of intraluminal 
thrombus and aneurysm size > 15 mm.2 Therefore, we 
could not detect the difference between cases of complete 
occlusion with and without WCS according to the radio-
logical and clinical outcomes, which were both excellent. 
Our study was also retrospective in nature. Despite these 
limitations, this study focused on the role of WCS and 
revealed that WCS is one of the reliable markers for the 
long-term stability of complete occlusion after endovascu-
lar embolization of saccular aneurysms, which would lead 
to a good clinical outcome. In the future, a large prospec-
tive study will be necessary to confirm the clinical impor-
tance of WCS.
Conclusions
A WCS appeared in 15.4% of aneurysms after endo-
vascular coil embolization. The significant factor in the 
appearance of WCS was a small-necked aneurysm. The 
WCS was associated with the maintenance of complete 
occlusion. The WCS would be a good predictor of radio-
logical and clinical outcome.
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